Illumina to Announce First Quarter 2014 Financial Results on Tuesday, April 22, 2014

  Illumina to Announce First Quarter 2014 Financial Results on Tuesday, April
  22, 2014

Business Wire

SAN DIEGO -- April 7, 2014

Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for
first quarter 2014 following the close of market on Tuesday, April 22, 2014.

On the same day, at 2:30 p.m. Pacific Time (5:30 p.m. Eastern Time) Jay
Flatley, Chief Executive Officer, Francis deSouza, President, and Marc
Stapley, Senior Vice President and Chief Financial Officer, will host a
conference call with analysts, investors, and other interested parties to
discuss financial and operating results.

Conference Call Details

The conference call will begin at 2:30 p.m. Pacific Time (5:30 p.m. Eastern
Time) on Tuesday, April 22, 2014. Interested parties may listen to the call by
dialing 888-679-8033 (passcode: 81417326), or if outside North America, by
dialing +1-617-213-4846 (passcode: 81417326). Individuals may access the live
teleconference in the Investor Relations section of Illumina's web site under
the “Company” tab at www.illumina.com.

A replay of the conference call will be available from 9:30 p.m. Pacific Time
(12:30 a.m. Eastern Time) on April 22, 2014 through April 29, 2014 by dialing
888-286-8010 (passcode: 38433522), or if outside North America, by dialing
+1-617-801-6888 (passcode: 38433522).

About Illumina

Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer
of life science tools and integrated systems for the analysis of genetic
variation and function. We provide innovative sequencing and array-based
solutions for genotyping, copy number variation analysis, methylation studies,
gene expression profiling, and low-multiplex analysis of DNA, RNA and protein.
We also provide tools and services that are fueling advances in consumer
genomics and diagnostics. Our technology and products accelerate genetic
analysis research and its application, paving the way for molecular medicine
and ultimately transforming healthcare.

Contact:

Illumina, Inc.
Investors:
Rebecca Chambers, 858-255-5243
rchambers@illumina.com
or
Media:
Jennifer Temple, 858-882-6822
pr@illumina.com
 
Press spacebar to pause and continue. Press esc to stop.